Innovations in Placental Metabolism & Association With Antioxidants &

Status Suspended

Clinical Trial Summary

This research project aims to investigate, in an innovative way, the molecular pathophysiology of gestational complications induced by maternal obesity and gestational diabetes mellitus (GDM). These complications have an immediate impact on obstetric outcomes - such as pre-eclampsia and intrauterine growth restriction - as well as long-term consequences for the health of the mother and child. This proposal aims to advance the understanding of the relationship between subclinical maternal and placental inflammation with dietary components through a prospective cohort of pregnant women. To this end, a prospective cohort of pregnant women will be conducted with four follow-up waves: 13th-20th (baseline), 24th-28th, 32nd-36th gestational weeks and at the time of delivery. Retrospective data referring to the first trimester of pregnancy will be obtained from the medical records. Pregnant women will be invited to participate in the study by registering at the prenatal service. Women who start prenatal care with less than 13 weeks of gestation will be registered, for capture in the 2nd consultation. The initial sample calculation is 120 volunteers. Maternal blood samples will be collected at 2 times: 2nd trimester appointment and 3rd trimester appointment. Placental and umbilical cord blood samples will be collected immediately after delivery. Dietary consumption during pregnancy will be assessed by 2 24-hour recalls at each visit (1 in person and 1 by telephone). The identification of functional biomarkers in maternal blood and placenta will serve for prognostic purposes of gestational complications such as Gestational Diabetes Mellitus. The identification of dietary factors associated with obesity and gestational diabetes mellitus and associated complications will provide information that will serve as a basis for nutritional guidelines for pregnant women.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05174728
Study type	Observational
Source	Rio de Janeiro State University
Contact
Status	Suspended
Phase
Start date	July 20, 2017
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03249896` - Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes	N/A
Completed	`NCT06338254` - Efficacy of Percussion Massage Therapy Applied to the Lower Extremity on Pain, Edema in Pregnant Women	N/A
Recruiting	`NCT04825093` - Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19	N/A
Completed	`NCT04739462` - SMS Maama Project COVID-19	N/A
Recruiting	`NCT04519593` - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma	N/A
Recruiting	`NCT03313024` - Berlin-Brandenburg Pregnancy Cohort
Completed	`NCT02577536` - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting	`NCT06430853` - Psychobiological Interventions in Pregnancy	N/A
Not yet recruiting	`NCT06357962` - Semi-permanent Acupuncture Effect on Cervical Ripening	N/A
Not yet recruiting	`NCT03661749` - Urinary Protein to Creatinine Ratio in Term Pregnant Women	N/A
Completed	`NCT02970721` - Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Completed	`NCT02191774` - Medical Abortion up to 10 Weeks Gestation at Home
Completed	`NCT01322529` - Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be	N/A
Completed	`NCT00678080` - Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes	N/A
Completed	`NCT00746551` - Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment	Phase 4
Completed	`NCT00634530` - Impact of a Nutritional Intervention Program for Weight Control During Pregnancy	N/A
Completed	`NCT00197561` - Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection	Phase 3
Completed	`NCT05527327` - Pannus Retraction for Ultrasound Evaluation of the Obese Gravida: A Pilot Study	N/A
Recruiting	`NCT05551078` - Thrombophilia Screening After Severe IUGR
Recruiting	`NCT03100084` - PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Innovations in Placental Metabolism and Association With Antioxidants and Nutrients in Diabetes and Gestational Obesity — IMPACTING

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms